DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/2vqpjk/egypt_diabetes_car) has announced the addition of Global Markets Direct's new report "Egypt Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017" to their offering.
Egypt Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2017, a new report by Global Markets Direct, provides key market data on the Egypt Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct's team of industry experts.
- Market size and company share data for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Egypt Diabetes Care Devices market.
- F. Hoffmann-La Roche Ltd.
- Becton, Dickinson and Company
- Abbott Laboratories
- Bayer HealthCare AG
- sk AS
- Eli Lilly and Company
- LifeScan, Inc.
- Smiths Medical
- NIPRO CORPORATION
- ARKRAY, Inc.
- BIONIME Corporation
- Medtronic, Inc.
- Terumo Corporation
- Animas Corporation
For more information visit http://www.researchandmarkets.com/research/2vqpjk/egypt_diabetes_car
Source: Global Markets Direct